Fecal microbiota transplantation has therapeutic effects on chronic hepatits B patients via altering composition of gut microbiota

被引:0
|
作者
Jia-Min Lou [1 ,2 ]
Zhi-Gang Ren [1 ,2 ]
Ang Li [1 ,2 ]
Ben-Chen Rao [1 ,2 ]
Zu-Jiang Yu [1 ,2 ]
机构
[1] Department of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University
[2] Gene Hospital of Henan Province, Precision Medicine Center, the First Affiliated Hospital of Zhengzhou University
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R512.62 [];
学科分类号
100401 ;
摘要
Chronic hepatits B(CHB) is an increasingly disturbing public health issue worldwide. Currently, interferon and oral antiviral drugs such as entecavir(ETV) or tenofovir disoproxil fumarate(TDF) are two internationally recognized drugs for the treatment of CHB. However, the HBe Ag clearance or seroconversion rate is low even in patients with long-term antiviral therapy. Many patients have to increase the dosage of antiviral therapy drugs [1].
引用
收藏
页码:486 / 487
页数:2
相关论文
共 50 条
  • [41] Complex Probiotics Ameliorate Fecal Microbiota Transplantation-Induced IBS in Mice via Gut Microbiota and Metabolite Modulation
    Gao, Yuan
    Borjihan, Qinggele
    Zhang, Weiqin
    Li, Lu
    Wang, Dandan
    Bai, Lu
    Zhu, Shiming
    Chen, Yongfu
    NUTRIENTS, 2025, 17 (05)
  • [42] Gut Microbiota Composition and Fecal Metabolic Phenotype in Patients With Acute Anterior Uveitis
    Huang, Xinyue
    Ye, Zi
    Cao, Qingfeng
    Su, Guannan
    Wang, Qingfeng
    Deng, Jing
    Zhou, Chunjiang
    Kijlstra, Aize
    Yang, Peizeng
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (03) : 1523 - 1531
  • [43] FECAL MICROBIOTA TRANSPLANTATION DOES NOT AFFECT THE RESISTOMES OF PATIENTS WITH CHRONIC POUCHITIS
    Claytor, Jennifer
    Lin, Din L.
    Magnaye, Kevin M.
    Guerrero, Yanedth E. Sanchez
    Langelier, Charles
    Lynch, Susan
    El-Nachef, Najwa
    GASTROENTEROLOGY, 2024, 166 (05) : S177 - S177
  • [44] Successful Outcomes of Fecal Microbiota Transplantation in Patients with Chronic Liver Disease
    Meiphani, Alireza
    Ramesh, Mayur
    Salgia, Reena
    HEPATOLOGY, 2016, 64 : 1016A - 1017A
  • [45] The efficacy of fecal microbiota transplantation for patients with chronic pouchitis: A case series
    Nishida, Atsushi
    Imaeda, Hirotsugu
    Inatomi, Osamu
    Bamba, Shigeki
    Sugimoto, Mitsushige
    Andoh, Akira
    CLINICAL CASE REPORTS, 2019, 7 (04): : 782 - 788
  • [46] Fecal microbiome transplantation alleviates manganese-induced neurotoxicity by altering the composition and function of the gut microbiota via the cGAS-STING/NLRP3 pathway
    Liu, Jingjing
    Zhang, Zhimin
    Zhong, Shiyin
    Zhang, Xin
    Yang, Jirui
    Zhou, Qiongli
    Wang, Diya
    Chang, Xuhong
    Wang, Hui
    SCIENCE OF THE TOTAL ENVIRONMENT, 2024, 951
  • [47] DONOR SELECTION INFLUENCES THERAPEUTIC EFFECTS OF FECAL MICROBIOTA TRANSPLANTATION FOR ULCERATIVE COLITIS
    Haga, Keiichi
    Ishikawa, Dai
    Okahara, Koki
    Nomura, Kei
    Ito, Shoko
    Takahashi, Masahito
    Shibuya, Tomoyoshi
    Nagahara, Akihito
    GASTROENTEROLOGY, 2020, 158 (03) : S58 - S59
  • [48] DONOR SELECTION INFLUENCES THERAPEUTIC EFFECTS OF FECAL MICROBIOTA TRANSPLANTATION FOR ULCERATIVE COLITIS
    Haga, Keiichi
    Ishikawa, Dai
    Okahara, Koki
    Nomura, Kei
    Ito, Shoko
    Takahashi, Masahito
    Shibuya, Tomoyoshi
    Nagahara, Akihito
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S36 - S36
  • [49] Fecal virus transplantation has more moderate effect than fecal microbiota transplantation on changing gut microbial structure in broiler chickens
    Feng, Hongyu
    Xiong, Jiaying
    Liang, Saisai
    Wang, Yinlong
    Zhu, Yufei
    Hou, Qihang
    Yang, Xiaojun
    Yang, Xin
    POULTRY SCIENCE, 2024, 103 (02)
  • [50] Is fecal microbiota transplantation currently a therapeutic option in patients with irritable bowel syndrome?
    Quera, Rodrigo
    Sedano, Rocio
    Nunez, Paulina
    REVISTA MEDICA DE CHILE, 2020, 148 (05) : 713 - 714